BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29083949)

  • 21. Role of Krev Interaction Trapped-1 in Prostacyclin-Induced Protection against Lung Vascular Permeability Induced by Excessive Mechanical Forces and Thrombin Receptor Activating Peptide 6.
    Meliton A; Meng F; Tian Y; Shah AA; Birukova AA; Birukov KG
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):834-43. PubMed ID: 25923142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of lung endothelial permeability and inflammatory responses by prostaglandin A2: role of EP4 receptor.
    Ohmura T; Tian Y; Sarich N; Ke Y; Meliton A; Shah AS; Andreasson K; Birukov KG; Birukova AA
    Mol Biol Cell; 2017 Jun; 28(12):1622-1635. PubMed ID: 28428256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization.
    Kratzer E; Tian Y; Sarich N; Wu T; Meliton A; Leff A; Birukova AA
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):688-97. PubMed ID: 22842495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.
    Wang L; Sammani S; Moreno-Vinasco L; Letsiou E; Wang T; Camp SM; Bittman R; Garcia JG; Dudek SM
    Crit Care Med; 2014 Mar; 42(3):e189-99. PubMed ID: 24335440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection.
    Birukova AA; Chatchavalvanich S; Oskolkova O; Bochkov VN; Birukov KG
    Microvasc Res; 2007 May; 73(3):173-81. PubMed ID: 17292425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging-Related Accumulation of Truncated Oxidized Phospholipids Augments Infectious Lung Injury and Endothelial Dysfunction via Cluster of Differentiation 36-Dependent Mechanism.
    Ke Y; Karki P; Li Y; Promnares K; Zhang CO; Eggerman TL; Bocharov AV; Birukova AA; Birukov KG
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GRP78 is a novel receptor initiating a vascular barrier protective response to oxidized phospholipids.
    Birukova AA; Singleton PA; Gawlak G; Tian X; Mirzapoiazova T; Mambetsariev B; Dubrovskyi O; Oskolkova OV; Bochkov VN; Birukov KG
    Mol Biol Cell; 2014 Jul; 25(13):2006-16. PubMed ID: 24829380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy inhibitor 3-methyladenine protects against endothelial cell barrier dysfunction in acute lung injury.
    Slavin SA; Leonard A; Grose V; Fazal F; Rahman A
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L388-L396. PubMed ID: 29074492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.
    Konya V; Üllen A; Kampitsch N; Theiler A; Philipose S; Parzmair GP; Marsche G; Peskar BA; Schuligoi R; Sattler W; Heinemann A
    J Allergy Clin Immunol; 2013 Feb; 131(2):532-40.e1-2. PubMed ID: 22704539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of truncated oxidized phospholipids in acute endothelial barrier dysfunction caused by particulate matter.
    Karki P; Meliton A; Shah A; Tian Y; Ohmura T; Sarich N; Birukova AA; Birukov KG
    PLoS One; 2018; 13(11):e0206251. PubMed ID: 30419037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac.
    Birukov KG; Bochkov VN; Birukova AA; Kawkitinarong K; Rios A; Leitner A; Verin AD; Bokoch GM; Leitinger N; Garcia JG
    Circ Res; 2004 Oct; 95(9):892-901. PubMed ID: 15472119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.
    Burg N; Swendeman S; Worgall S; Hla T; Salmon JE
    Arthritis Rheumatol; 2018 Nov; 70(11):1879-1889. PubMed ID: 29781582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Afadin controls p120-catenin-ZO-1 interactions leading to endothelial barrier enhancement by oxidized phospholipids.
    Birukova AA; Fu P; Wu T; Dubrovskyi O; Sarich N; Poroyko V; Birukov KG
    J Cell Physiol; 2012 May; 227(5):1883-90. PubMed ID: 21732359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction.
    Meng F; Meliton A; Moldobaeva N; Mutlu G; Kawasaki Y; Akiyama T; Birukova AA
    Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(5):L452-63. PubMed ID: 25539852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.
    Singleton PA; Moreno-Vinasco L; Sammani S; Wanderling SL; Moss J; Garcia JG
    Am J Respir Cell Mol Biol; 2007 Aug; 37(2):222-31. PubMed ID: 17395891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids.
    Birukova AA; Zebda N; Fu P; Poroyko V; Cokic I; Birukov KG
    J Cell Physiol; 2011 Aug; 226(8):2052-62. PubMed ID: 21520057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostacyclin post-treatment improves LPS-induced acute lung injury and endothelial barrier recovery via Rap1.
    Birukova AA; Meng F; Tian Y; Meliton A; Sarich N; Quilliam LA; Birukov KG
    Biochim Biophys Acta; 2015 May; 1852(5):778-91. PubMed ID: 25545047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
    Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
    Leitinger N
    Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.